PACB - Pacific Biosciences of California, Inc.
| Previous Close | 3.92 |
| Open | 3.94 |
| Bid | 3.60 x 3200 |
| Ask | 3.90 x 1800 |
| Day's Range | 3.64 - 3.98 |
| 52 Week Range | 2.02 - 5.70 |
| Volume | 3,574,873 |
| Avg. Volume | 866,395 |
| Market Cap | 505.089M |
| Beta | 3.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.82 |
| Earnings Date | Jul 31, 2018 - Aug 6, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.51 |
- Simply Wall St.•6 hours ago
Pacific Biosciences of California Inc’s (NASDAQ:PACB) Earnings Dropped -17.25%, How Did It Fare Against The Industry?
For investors, increase in profitability and industry-beating performance can be essential considerations in an investment. Below, I will examine Pacific Biosciences of California Inc’s (NASDAQ:PACB) track record on a highRead More...
- Motley Fool•2 days ago
Better Buy: Illumina, Inc. vs. Pacific Biosciences of California
Which stock wins in a match-up between these two gene-sequencing leaders?
- Zacks•13 days ago
Pacific Biosciences to Gain From New Genome Sequencing Tools
Pacific Biosciences' (PACB) new multiplexing kit to make genome sequencing faster and cost-effective.
- Motley Fool•16 days ago
Is This Why Pacific Biosciences of California Surged This Week?
Investors appear pleased with the Sequel System's latest update.
- GlobeNewswire•17 days ago
Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program
MENLO PARK, Calif., June 07, 2018-- Pacific Biosciences of California Inc., today announced that obtaining microbial genomes with high accuracy and contiguity has become faster and more affordable thanks ...
- GlobeNewswire•18 days ago
Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria
The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio). Infecting tens of millions of people worldwide every year, these bacteria have been collected by the National Collection of Type Cultures (NCTC) and include deadly strains of plague, dysentery and cholera. Set up in 1920, the NCTC is the longest established collection of bacteria in the world.
- Zacks•23 days ago
Why Is Pacific Biosciences (PACB) Down 6.7% Since its Last Earnings Report?
Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire•2 months ago
Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore
Pacific Biosciences of California, Inc. (PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore will refrain from offering “2D” sequencing products through the end of 2023 in the United Kingdom and Germany. Pacific Biosciences had previously filed claims in the High Court of England and Wales and in the District Court of Mannheim, Germany against Oxford Nanopore for infringement of EP Patent Nos. 3045542 and 3170904 (collectively, the “‘542 and ‘904 Patents”), and Oxford Nanopore had countered by filing claims against Pacific Biosciences for infringement of EP Patent No. 1192453 (the “‘453 Patent”) in the same jurisdictions.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of PACB earnings conference call or presentation 2-May-18 8:30pm GMT
Q1 2018 Pacific Biosciences of California Inc Earnings Call
- Motley Fool•2 months ago
Here's Why Pacific Biosciences of California Is Falling Today
Disappointing quarterly results weighed on the stock.
- Motley Fool•2 months ago
For Pacific Biosciences of California, a First Quarter Hurt by Shipment Delays
The gene-sequencing company received plenty of orders for its Sequel systems in the first quarter, but customers weren't ready for most of them.
- Zacks•2 months ago
Pacific Biosciences (PACB) Loss Wider Than Expected in Q1
Pacific Biosciences (PACB) Q1 earnings and revenues miss estimates; Sequel orders rise.
- Benzinga•2 months ago
Benzinga's Daily Biotech Pulse: Achaogen Slumps On Mixed FDA Panel Vote, Pacific Biosciences Sinks On Q1 Miss
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks ( Stocks hitting 52-week highs on May 2 ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Eleven Biotherapeutics ...
- Associated Press•2 months ago
Pacific Biosciences: 1Q Earnings Snapshot
The Menlo Park, California-based company said it had a loss of 20 cents per share. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•2 months ago
Pacific Biosciences of California, Inc. Announces First Quarter 2018 Financial Results
MENLO PARK, Calif., May 02, 2018-- Pacific Biosciences of California, Inc. today announced financial results for its first quarter ended March 31, 2018.. Total revenue for the first quarter of 2018 was ...
- GlobeNewswire•2 months ago
Factors of Influence in 2018, Key Indicators and Opportunity within Bottomline Technologies, SkyWest, Pacific Biosciences of California, Argos Therapeutics, Luminex, and Fiserv — New Research Emphasizes Economic Growth
NEW YORK, April 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- PR Newswire•2 months ago
GENEWIZ And Pacific Biosciences Announce Winner Of The 2017 Structural Variant SMRT® Grant Program
WINNER TO RECEIVE LONG-READ WHOLE GENOME SEQUENCING ON THE PACBIO® SEQUEL® SYSTEM MENLO PARK, Calif. and SOUTH PLAINFIELD, N.J. , April 24, 2018 /PRNewswire/ -- Pacific Biosciences of California , Inc. ...
- GlobeNewswire•2 months ago
Pacific Biosciences of California, Inc. First Quarter 2018 Financial Results Call
MENLO PARK, Calif., April 20, 2018-- Pacific Biosciences of California, Inc. will hold its quarterly conference call to discuss its First Quarter 2018 Financial Results on Wednesday, May 2, 2018, at 4:30pm ...
- Zacks•2 months ago
Pacific Biosciences Gains as HudsonAlpha Picks Sequel System
Pacific Biosciences (PACB) sees increasing use of Sequel Sequencing System in pediatric and plant biologic case studies.
- GlobeNewswire•2 months ago
HudsonAlpha Using PacBio Sequencing for Childhood Developmental Disabilities Research
MENLO PARK, Calif., April 11, 2018-- Pacific Biosciences of California, Inc., the leader in long-read, high-resolution sequencing, today announced that the HudsonAlpha Institute for Biotechnology is using ...
- GlobeNewswire•3 months ago
Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad
MENLO PARK, Calif., March 27, 2018-- Pacific Biosciences of California, Inc., the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio ® Sequel ® Systems that ...
- Zacks•4 months ago
Pacific Biosciences Unveils New Version of Sequel Software
Pacific Biosciences (PACB) enhances performance and cost-effectiveness of the Sequel System.
